Contacts
Info
There's a scientific breakthrough in your medicine cabinet. But how did it get there? At a time when medicines are helping us all live longer and healthier lives, this podcast...
show more
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
show less
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
Making Medicine
Making Medicine
CEO Series Part 1: Sherine Chan, CEO & Co-founder of Neuroene Therapeutics
28 JUN 2024 · As part of our inaugural CEO series, we're excited to welcome https://www.linkedin.com/in/sherinechan/, the CEO and Co-Founder of https://neuroenetherapeutics.com/.
In this episode, Sherine shares her journey from academia to helming a cutting-edge biotech company. She explores the groundbreaking work her company is pioneering in targeting the powerhouses of cells: mitochondria. Sherine also dives into the influence of the Inflation Reduction Act on the development of small-molecule drugs
We also discuss:Â
- Neuroene Therapeutics' ongoing projects.
- The critical role of mitochondrial dysfunction in neurological conditions such as epilepsy, Parkinson's, and mitochondrial disorders.
- Sherine's insights for aspiring entrepreneurs and scientists.
Dispelling Misconceptions in Biopharmaceutical IP Regulation
3 MAY 2024 · On World IP Day, https://www.linkedin.com/in/kirsten-axelsen-5129b15/, Senior Advisor of the https://incubatecoalition.org/policylab/, joins host John Stanford to announce the newest whitepaper, delve into the myths and realities surrounding IP in the pharmaceutical industry, explore the dynamics of patent regulations, and touch on the contentious discussions around patent thickets and pharmaceutical pricing under new legislative environments like the Inflation Reduction Act.
Join us as we also discuss:
- What to expect out of the Incubate Policy Lab
- The role that venture investment plays in advancing promising science and technology.
- The latest whitepaper that addresses misconceptions about IP
- The implications of IRA policies in weakening the generics industry, potentially disrupting the balance that has historically led to affordable drug pricing post-patent expiration.
When the Feds Come Marching In: A Deep Dive on The Bayh-Dole Act
11 APR 2024 · https://www.linkedin.com/in/joseph-allen-653b7415?challengeId=AQHta2L1g-_oVAAAAY3qI9-ABoqlfXDhYCfBgEMk-QYWVNdBgjvnygPKGPrhbApvSlayo6tZvzsiyNmtPIfTJOQLqqCzaZv4-Q&submissionId=5939c4c6-f1b1-b717-0db6-209df587d55e&challengeSource=AgGAVdzQ7-NDgwAAAY3qI-1JQC4kmcR2Q8xBCg35HKJ1uUfNqTtiyAUgNKGUB_4&challegeType=AgF1PyvqlgxteAAAAY3qI-1MAp5CUs0Dv2Ih0TUvhAJeQadoGlG2ZQs&memberId=AgFrt7sIyiS1uwAAAY3qI-1PifutzHcC_RoXlHW-Xx-qewA&recognizeDevice=AgHLalLSJ0gRnQAAAY3qI-1SZyahe1nmIofJ-aJUsAuliLguYgTi, Executive Director of https://bayhdolecoalition.org/, was at the forefront of the Bayh-Dole Act back in December 1980, which allowed researchers to own inventions resulting from federally funded research. However, 43 years later, the March-In Rights framework proposed by the Biden administration threatens to weaken America’s innovation. In this episode, Joe delves into the potential implications of this framework on drug pricing, the pipeline, and overall innovation.
Join us as we discuss:
- The significance of the Bayh-Dole Act and intellectual property in transforming how America drives innovation.
- Why public-private partnerships and collaboration in the medical field are key for funding research projects.
- The implications of enacting March-In Rights on the drug development pipeline
Beyond Medicine: Solving Disparities in Cancer Care
13 SEP 2023 · How can we create better outcomes for cancer patients?
That’s the big goal https://www.linkedin.com/in/mohitmanrao/ is aiming for in his work as SVP & Head of US Oncology at https://www.astrazeneca.com/. In this episode, Mohit shares his perspective on the future of oncology and the pursuit of patient-centric care in a post-Inflation Reduction Act world.
Join us as we discuss:
- AstraZeneca's goal of launching 15 new drugs by 2030
- Solving for disparities in care and improving health equity
- Timeline for drug development and its effect on patient outcomes
Balancing Access and Affordability in the Future of Healthcare
23 AUG 2023 · Can we create a future healthcare system that is accessible and affordable for all patients?
That’s the major question that https://www.linkedin.com/in/mary-grealy-878a1b4/, CEO of Healthcare Leadership Council, is trying to answer through her work. Mary, a former speech pathologist turned lawyer, shares insights from her unique journey from the healthcare field to advocating for patient-centered, value-based healthcare systems. In this wide-ranging conversation, Mary shares the challenges faced in the industry but also her hope for a future where patients are empowered through collaboration and innovation.
Join us as we discuss:
- Why collaboration between stakeholders is key
- Practical tips for advocates to make a compelling case to Congress
- The potential effects of the new price-setting system
- The impact of proposed legislation on treatments and cures
Making Patients the Center of U.S. Healthcare Reform
11 MAY 2023 · With recent movement in healthcare including President Biden’s Cancer Moonshot and the Inflation Reduction Act, one thing is clear: American healthcare is at a crossroads.
As we begin to tackle the conversation of healthcare reform, how can we rebuild the system around patients?
In this episode, https://www.linkedin.com/in/mjimeson/, Executive Director of https://accessandaffordability.org/, joins the show to explain how the system was never designed for patients, the benefits of a patient-centric system, and what the future holds for the industry.
Join us as we discuss:
- Why patient-centricity is notably absent in our healthcare system
- MacKay’s op-ed in response to President Biden’s SOTU
- The impact of The Inflation Reduction Act and Centers for Medicare & Medicaid Services on today’s healthcare landscape
- The true human impact of medicines
MacKay’s Op-Ed: https://www.statnews.com/2023/02/09/state-of-the-union-highlights-americas-awkward-conversation-on-science-medicine-and-financing-the-development-of-new-medicines/
MacKay’s Bio:
https://accessandaffordability.org/person/02-mackay-jimeson/
Innovations in Women’s Health & Entrepreneurship
31 MAR 2023 · Even though 80% of the household decisions around health are made by women, only 4% of research and funding goes towards women’s health research.
In today’s episode, https://www.linkedin.com/in/natalie-buford-young-55b10b/, Chief Executive Officer at https://sb.co/, joins us to discuss Springboard’s mission and how they are exploring a designated network to create pathways for emerging female innovators.
We also get to hear about Natalie's experience testifying on the Hill to advocate for reducing the decline of women's entrepreneurship.
Join us as we discuss:
· Innovation in digital health and life sciences;
· The Women's Health Innovation Coalition; and
· Increasing diversity in clinical trials.
The Inflation Reduction Act: A Big Issue for Small-Molecule Medicine
24 MAR 2023 · Runaway inflation and economic instability is terrible for just about everybody, but are efforts to tackle this problem creating more?
To answer that, Kirsten Axelsen, Senior Policy Advisor at DLA Piper, joins the show to break down all the effects The Inflation Reduction act is having upon medicine,
We discuss:
- The potential negative impacts on small-molecule medicine
- How the act affects patents and generic medicine
- Why we may see declines in small-molecule medicine research
From the JP Morgan Conference: The Impact of the Inflation Reduction Act
23 JAN 2023 · John was at the JP Morgan conference and is here to discuss the key takeaways of the Inflation Reduction Act: the small-molecule penalty, the value of small-molecule drugs, the importance of incentivizing post-approval research, intellectual property, and non-coverage decisions at CMS. You’ll also hear John’s take on the demand for a more pro-patient agenda. There was a lot of focus on the role of policy and government, specifically in relation to the inflation reduction act and its impact on the life science and venture capital industries.
Ready to reaffirm its values, Incubate will be focusing its energy on working with the White House and Congress to make necessary amendments to the legislation. They’ll also have a focus on education and awareness to ensure that policymakers understand the critical role they play in the healthcare landscape.
Join us as we discuss:
- Why is there excitement for 2023 in the biotech sector, but also some anxiety?
- How does the organization, Incubate, plan to address the inflation reduction act?
- What Congress can be doing to create a more pro-patient agenda?
Drug Investment Under the Inflation Reduction Act
12 DEC 2022 · How will the Inflation Reduction Act affect life sciences startups, current and future revenues, and drug investment? What will happen to patients amidst the aftermath of unintended consequences? There aren’t too many people who know more about the ins and outs than the fine folks at DLA Piper.
One of the biggest interventions in drug pricing since the Medicare Modernization Act was passed, listen to the inside scoop on what this means for the future of drugs.
Join us as we discuss:
-What drug price negotiations will look like under the act
-How brand competition will play out
-Which drugs and stakeholders will be affected
There's a scientific breakthrough in your medicine cabinet. But how did it get there? At a time when medicines are helping us all live longer and healthier lives, this podcast...
show more
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
show less
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
Information
| Author | Sweet Fish |
| Organization | Sweet Fish |
| Categories | Health & Fitness |
| Website | www.spreaker.com |
| - |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
